Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Multi-country Cohort Study of the Effectiveness and Safety of Filgotinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis

NCT05817942 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.

NCT NCT05817942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05817942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Multi-country Cohort Study of the Effectiveness and Safety of Filgotinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Lead sponsor
Alfasigma S.p.A.
Phase
Observational
Overall status
Active, not recruiting
Start date
June 12, 2023
Completion date
December 31, 2027
Enrollment
509 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis